Skip to content
Advertisement

Baby botulism outbreak: FDA still doesn't know cause—or how to prevent it

In the end, the three companies involved all point the finger at each other.

schedule 22:36 visibility 6 views
Baby botulism outbreak: FDA still doesn't know cause—or how to prevent it
Source: Ars Technica

The Food and Drug Administration this week posted what critics call an "underwhelming" epilogue to the devastating outbreak of botulism in babies, which was linked to spore-contaminated formula made by ByHeart. Despite clear tracking of the contamination, the regulator still doesn't know how the bacteria arrived in the formula—or how to prevent it from happening again.

"The FDA's investigation into the root cause is ongoing with a focus on ingredients," the agency reported.

In the void, three companies at the center of the investigation are left pointing fingers at each other, with none publicly taking responsibility for the contamination.

Read full article

Comments

newspaper

Originally published at

Ars Technica

open_in_new Read Full Article

Related Articles

Read More

DRC: How disinformation worsens Ebola epidemic
Health

DRC: How disinformation worsens Ebola epidemic

It is not only a deadly Ebola variant causing concern for health workers in DR Congo. Rumors and disinformation hinder efforts to contain the virus. The patterns are well-known — and could be confronted.

DW News
Scientists discover why ozempic may not work for some people
Health

Scientists discover why ozempic may not work for some people

Scientists have identified genetic variants that may make some people less responsive to GLP-1 drugs used to treat Type 2 diabetes. Roughly 10% of the population carries these variants, which appear to cause a mysterious form of "GLP-1 resistance."...

Science Daily